Search research articles
Contact Us
Filters
Showing results (141-150 of 355) with videos related to
Page
of 36
Sort By:
British Journal of Haematology
|
May 16, 2023
Long non-coding RNAs associated with transcriptomic signatures and treatment outcome in diffuse large B-cell lymphoma
Gerben Duns, Melanie Winkle, Lauren Chong, et al.
Haematologica
|
August 2, 2016
Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas
Roopesh Kansara, Joseph M Connors, Kerry J Savage, et al.
Blood Cancer Journal
|
March 14, 2018
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era
Rebecca L King, Grzegorz S Nowakowski, Thomas E Witzig, et al.
Blood Advances
|
February 11, 2021
Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors
Vignesh Shanmugam, Jeffrey W Craig, Laura K Hilton, et al.
Blood Advances
|
August 1, 2020
Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma
Diego Villa, Laurie H Sehn, Kerry J Savage, et al.
Journal of Internal Medicine
|
July 10, 2023
Novel precision medicine approaches and treatment strategies in hematological malignancies
Richard Rosenquist, Elsa Bernard, Tom Erkers, et al.
British Journal of Haematology
|
December 11, 2019
Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphoma
Anna R Hayden, Derrick G Lee, Diego Villa, et al.
Blood
|
December 16, 2014
Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses
Yong Chan Kim, Ai-Hong Zhang, Yan Su, et al.
Haematologica
|
October 2, 2025
Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy
Jiayu Yang, Anna R Hayden, Diego Villa, et al.
Blood Advances
|
February 21, 2025
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
Katja Gutmair, Diego Villa, Nicholas Cunningham, et al.
Page
of 36
Search research articles
Search
Showing results (141-150 of 355) with videos related to
Sort By:
Page
of 36
British Journal of Haematology
|
May 16, 2023
Long non-coding RNAs associated with transcriptomic signatures and treatment outcome in diffuse large B-cell lymphoma
Gerben Duns, Melanie Winkle, Lauren Chong, et al.
Haematologica
|
August 2, 2016
Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas
Roopesh Kansara, Joseph M Connors, Kerry J Savage, et al.
Blood Cancer Journal
|
March 14, 2018
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era
Rebecca L King, Grzegorz S Nowakowski, Thomas E Witzig, et al.
Blood Advances
|
February 11, 2021
Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors
Vignesh Shanmugam, Jeffrey W Craig, Laura K Hilton, et al.
Blood Advances
|
August 1, 2020
Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma
Diego Villa, Laurie H Sehn, Kerry J Savage, et al.
Journal of Internal Medicine
|
July 10, 2023
Novel precision medicine approaches and treatment strategies in hematological malignancies
Richard Rosenquist, Elsa Bernard, Tom Erkers, et al.
British Journal of Haematology
|
December 11, 2019
Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphoma
Anna R Hayden, Derrick G Lee, Diego Villa, et al.
Blood
|
December 16, 2014
Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses
Yong Chan Kim, Ai-Hong Zhang, Yan Su, et al.
Haematologica
|
October 2, 2025
Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy
Jiayu Yang, Anna R Hayden, Diego Villa, et al.
Blood Advances
|
February 21, 2025
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
Katja Gutmair, Diego Villa, Nicholas Cunningham, et al.
Page
of 36